145 related articles for article (PubMed ID: 31015189)
1. Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center.
Giardino G; Radwan N; Koletsi P; Morrogh DM; Adams S; Ip W; Worth A; Jones A; Meyer-Parsonson I; Gaspar HB; Gilmour K; Davies EG; Ladomenou F
Blood; 2019 Jun; 133(24):2586-2596. PubMed ID: 31015189
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study.
Deshpande DR; Demirdag YY; Marsh RA; Sullivan KE; Orange JS;
J Clin Immunol; 2021 Jan; 41(1):29-37. PubMed ID: 32949294
[TBL] [Abstract][Full Text] [Related]
3. Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development.
Marcovecchio GE; Bortolomai I; Ferrua F; Fontana E; Imberti L; Conforti E; Amodio D; Bergante S; Macchiarulo G; D'Oria V; Conti F; Di Cesare S; Fousteri G; Carotti A; Giamberti A; Poliani PL; Notarangelo LD; Cancrini C; Villa A; Bosticardo M
Front Immunol; 2019; 10():447. PubMed ID: 30949166
[TBL] [Abstract][Full Text] [Related]
4. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome.
Davis CM; Kancherla VS; Reddy A; Chan W; Yeh HW; Noroski LM; Rosenblatt H; Shearer WT; Chinen J
J Allergy Clin Immunol; 2008 Dec; 122(6):1194-9. PubMed ID: 18789819
[TBL] [Abstract][Full Text] [Related]
5. Long-term assessment of T-cell populations in DiGeorge syndrome.
Chinen J; Rosenblatt HM; Smith EO; Shearer WT; Noroski LM
J Allergy Clin Immunol; 2003 Mar; 111(3):573-9. PubMed ID: 12642839
[TBL] [Abstract][Full Text] [Related]
6. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.
Müller W; Peter HH; Wilken M; Jüppner H; Kallfelz HC; Krohn HP; Miller K; Rieger CH
Eur J Pediatr; 1988 Jun; 147(5):496-502. PubMed ID: 3044796
[TBL] [Abstract][Full Text] [Related]
7. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.
Eberle P; Berger C; Junge S; Dougoud S; Büchel EV; Riegel M; Schinzel A; Seger R; Güngör T
Clin Exp Immunol; 2009 Feb; 155(2):189-98. PubMed ID: 19040613
[TBL] [Abstract][Full Text] [Related]
8. Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions.
Giacomelli M; Kumar R; Soresina A; Tamassia N; Lorenzini T; Moratto D; Gasperini S; Cassatella M; Plebani A; Lougaris V; Badolato R
J Allergy Clin Immunol; 2016 Jul; 138(1):229-240.e3. PubMed ID: 26875746
[TBL] [Abstract][Full Text] [Related]
9. Reduced frequency of peripheral CD4+CD45RA+CD31+ cells and autoimmunity phenomena in patients affected by Del22q11 syndrome.
Ricci S; Masini M; Valleriani C; Casini A; Cortimiglia M; Grisotto L; Canessa C; Indolfi G; Lippi F; Azzari C
Clin Immunol; 2018 Mar; 188():81-84. PubMed ID: 29292084
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms of functional natural killer deficiency in patients with partial DiGeorge syndrome.
Zheng P; Noroski LM; Hanson IC; Chen Y; Lee ME; Huang Y; Zhu MX; Banerjee PP; Makedonas G; Orange JS; Shearer WT; Liu D
J Allergy Clin Immunol; 2015 May; 135(5):1293-302. PubMed ID: 25748067
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome.
Tison BE; Nicholas SK; Abramson SL; Hanson IC; Paul ME; Seeborg FO; Shearer WT; Perez MD; Noroski LM; Chinen J
J Allergy Clin Immunol; 2011 Nov; 128(5):1115-7.e1-3. PubMed ID: 21835443
[No Abstract] [Full Text] [Related]
12. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.
Froňková E; Klocperk A; Svatoň M; Nováková M; Kotrová M; Kayserová J; Kalina T; Keslová P; Votava F; Vinohradská H; Freiberger T; Mejstříková E; Trka J; Sedivá A
PLoS One; 2014; 9(12):e114514. PubMed ID: 25485546
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.
Patel PK; Chinga ML; Yilmaz M; Joychan S; Ujhazi B; Ellison M; Gordon S; Nieves D; Csomos K; Eslin D; Afify ZA; Meznarich J; Bohnsack J; Walkovich K; Seidel MG; Sharapova S; Boyarchyk O; Latysheva E; Tuzankina I; Shaker AB; Ayala I; Sriaroon P; Westermann-Clark E; Walter JE
J Clin Immunol; 2024 Jan; 44(2):42. PubMed ID: 38231436
[TBL] [Abstract][Full Text] [Related]
14. Immune system defects in DiGeorge syndrome and association with clinical course.
Nain E; Kiykim A; Ogulur I; Kasap N; Karakoc-Aydiner E; Ozen A; Baris S
Scand J Immunol; 2019 Nov; 90(5):e12809. PubMed ID: 31322747
[TBL] [Abstract][Full Text] [Related]
15. Early development of immunity in diGeorge syndrome.
Sedivá A; Bartůnková J; Zachová R; Poloucková A; Hrusák O; Janda A; Kocárek E; Novotná D; Novotná K; Klein T
Med Sci Monit; 2005 Apr; 11(4):CR182-7. PubMed ID: 15795698
[TBL] [Abstract][Full Text] [Related]
16. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
Kanaya Y; Ohga S; Ikeda K; Furuno K; Ohno T; Takada H; Kinukawa N; Hara T
Clin Exp Immunol; 2006 Apr; 144(1):85-93. PubMed ID: 16542369
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
McLean-Tooke A; Barge D; Spickett GP; Gennery AR
Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).
Finocchi A; Di Cesare S; Romiti ML; Capponi C; Rossi P; Carsetti R; Cancrini C
Pediatr Allergy Immunol; 2006 Aug; 17(5):382-8. PubMed ID: 16846458
[TBL] [Abstract][Full Text] [Related]
19. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity.
Moylett EH; Wasan AN; Noroski LM; Shearer WT
Clin Immunol; 2004 Jul; 112(1):106-12. PubMed ID: 15207787
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of clinical dysimmune manifestations in a cohort of 86 children with 22q11.2 deletion syndrome: A retrospective study in France.
Mahé P; Nagot N; Portales P; Lozano C; Vincent T; Sarda P; Perez MJ; Amedro P; Marin G; Jeziorski E
Am J Med Genet A; 2019 Nov; 179(11):2207-2213. PubMed ID: 31471951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
